Month: November 2024

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)...

HealthArc Joins athenahealth’s Marketplace Program to Streamline Remote Care, Patient Outcomes, and Billing Process

HealthArc's unified remote care management platform integrates with athenahealth'sEHR to automate clinical documentation, enhance patient engagement and boost reimbursements for...

Patient Engagement Technology Market to grow by USD 37.41 Billion from 2024-2028, driven by rising chronic disease cases and AI’s impact on market trends – Technavio

NEW YORK, Nov. 27, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global patient engagement technology...

error: Content is protected !!